Aisling O'Leary

Dr. Aisling O'Leary is a Senior Lecturer at the School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). She holds a PhD in Pharmaceutical Chemistry from Trinity College Dublin and has extensive clinical pharmacy experience at St. James’s Hospital, Dublin. Her academic career includes teaching roles in clinical pharmacy and part-time involvement with the National Centre for Pharmacoeconomics. She oversees the National Hepatitis C Treatment Program outcomes registry and contributes to health technology assessments for medication reimbursement.

Dr. O'Leary's education includes a B.Sc. in Pharmacy and a PhD from Trinity College Dublin. Her research focuses on hepatitis C treatment, pharmacoeconomics, antimicrobial stewardship, and health system sustainability. She has published widely on topics like drug adherence, health economics, and outcomes-based treatment models. Her work integrates clinical practice, policy, and education to address public health challenges such as infectious diseases and medication safety.

• Education:
  • PhD in Pharmaceutical Chemistry (Trinity College Dublin)
  • B.Sc. (Pharm.) (Trinity College Dublin)
• Professional Roles:
  • Senior Lecturer at RCSI
  • Member of National Hepatitis C Treatment Programme Clinical Advisory Group
  • Former Lead of National Hepatitis C Outcomes Registry
• Research Focus:
  • Pharmacoeconomics and health technology assessment
  • Hepatitis C treatment optimization
  • Antimicrobial stewardship strategies
  • Healthcare sustainability and policy

Her recent publications emphasize sustainable healthcare practices, pharmacist-led care models, and outcomes-based drug evaluations. She actively contributes to interprofessional education and has supervised research on antimicrobial stewardship and hepatitis C treatment protocols.